相似文献/References:
[1]盛湲,李恒宇.从单细胞水平看肿瘤异质性[J].中华乳腺病杂志：电子版,2014,8(6):384.
[J].Chinese Journal of Breast Disease (Electronic Version),2014,8(1):384.
[2]柴凡,姜军.血清蛋白质组学在肿瘤研究中的现状及展望[J].中华乳腺病杂志：电子版,2007,1(2):36.
CHAI Fan,JIANG Jun.Status and prospect of selh_paperm proteomics in the tumor research[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):36.
[3]魏军民,侯明,李丽珍,等.小分子干扰RNA联合反义脱氧寡核苷酸靶向逆转人乳腺癌细胞MCF-7/ADR多药耐药的研究[J].中华乳腺病杂志：电子版,2008,2(4):436.
[4]张江宇.乳腺癌相关分子病理学标志物研究进展[J].中华乳腺病杂志：电子版,2008,2(6):677.
[5]张柏林.Fas及Fas配体基因多态性与肿瘤发生风险的关系[J].中华乳腺病杂志：电子版,2009,3(3):338.
[6]于治灏,李越,王欣.Angiomotin在乳腺癌中的研究进展[J].中华乳腺病杂志：电子版,2010,4(4):447.
[7]张金锋,张显玉,张国强,等.2014年圣安东尼奥乳腺癌研讨会报道:乳腺癌循环核酸检测最新进展[J].中华乳腺病杂志：电子版,2015,9(1):8.
[J].Chinese Journal of Breast Disease (Electronic Version),2015,9(1):8.
[8]杨涛,周炳刚,马秀芬,等.电化学疗法对乳腺癌MCF-7细胞凋亡及钙离子浓度的影响[J].中华乳腺病杂志：电子版,2015,9(1):12.
Study on relationship between breast cancer cell line MCF-7 the apoptosis inducing by electrochemical therapy and changes of Intracellular Ca2 +[J].Chinese Journal of Breast Disease (Electronic Version),2015,9(1):12.
[9]梁全琨,张永松,钟玲,等.新辅助化疗对腔镜乳腺癌改良根治术后并发症 及疗效的影响[J].中华乳腺病杂志：电子版,2015,9(1):18.
Impact of neoadjuvant chemotherapy on postoperative complications and effectiveness after endoscopic mastectomy for breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2015,9(1):18.
[10]郑以孜,邵志敏.2014年圣安东尼奥乳腺癌研讨会回顾[J].中华乳腺病杂志：电子版,2015,9(1):5.
The 2014 San Antonio Breast Cancer Symposium Review[J].Chinese Journal of Breast Disease (Electronic Version),2015,9(1):5.
[11]陈伟,季明华,唐金海. 乳腺癌紫杉醇耐药的机制[J].中华乳腺病杂志：电子版,2015,9(4):275.
[J].Chinese Journal of Breast Disease (Electronic Version),2015,9(1):275.
[12]李焱,鲁海玲,霍明鸣,等. 芳香化酶抑制剂耐药机制研究进展[J].中华乳腺病杂志：电子版,2017,11(3):171.
[J].Chinese Journal of Breast Disease (Electronic Version),2017,11(1):171.
[13]黄欣,陈畅,周易冬,等. 乳腺导管原位癌保留乳房手术后序贯放射治疗的研究进展[J].中华乳腺病杂志：电子版,2018,12(1):50.
[J].Chinese Journal of Breast Disease (Electronic Version),2018,12(1):50.